You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients

Article metrics

Article menu

Download PDFPDF

Connective tissue diseases
Original article
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients

 

Online download statistics by month:

Online download statistics by month: December 2017 to March 2024

AbstractFullPdf
Dec 201718182
Jan 2018696714
Feb 2018837024
Mar 201811111731
Apr 2018777810
May 2018949615
Jun 201856575
Jul 201848488
Aug 201894948
Sep 201862627
Oct 20181091096
Nov 20181901917
Dec 20182102109
Jan 201918418318
Feb 20191321308
Mar 201955555
Apr 201924249
May 201932326
Jun 2019313117
Jul 2019212213
Aug 2019181811
Sep 201916164
Oct 201935356
Nov 201920206
Dec 201914147
Jan 202021219
Feb 202015156
Mar 202020204
Apr 202021219
May 2020883
Jun 202014148
Jul 202023233
Aug 202017137
Sep 202040393
Oct 202031285
Nov 202019176
Dec 2020181810
Jan 202123209
Feb 2021872
Mar 2021201911
Apr 202115143
May 202120187
Jun 202127253
Jul 202115154
Aug 202114148
Sep 2021272314
Oct 2021171513
Nov 20218811
Dec 202118152
Jan 2022683
Feb 202212134
Mar 202216138
Apr 2022212921
May 2022403914
Jun 202228316
Jul 202218173
Aug 202226246
Sep 2022322438
Oct 202226244
Nov 202220179
Dec 2022161713
Jan 202311123
Feb 202336337
Mar 2023655
Apr 2023568
May 2023141210
Jun 202315116
Jul 2023101010
Aug 2023242310
Sep 202318188
Oct 202321218
Nov 202313134
Dec 202313124
Jan 202415159
Feb 20241193
Mar 202415143
Total27502697643